Eva Live Inc (GOAI) · Oct 19, 2026 · Share issuance
$10M equity facility — Up to $10M for 5M shares; 275,000 warrants at $0.01
Eva Live filed a prospectus supplement for its previously announced equity facility, enabling up to $10 million in stock sales but adding dilution risk.
Eva Live is building an AI-driven digital advertising and automation platform while broadening its technology footprint into adjacent ventures. This filing makes previously announced financing usable, not new. The September 17 equity purchase agreement—already disclosed in the September 23, 2026 8-K—gives Eva Live the right, but not the obligation, to sell stock to Hudson Global Ventures. 〔0〕
| Financing term | Filing disclosure |
|---|---|
| Maximum Put Shares | 5,000,000 shares |
| Maximum purchase price | $10,000,000 |
| Warrant shares | 275,000 shares |
| Warrant exercise price | $0.01 per share |
| Warrant term | Five years |
The practical change is access to potential capital, with dilution attached. The prospectus supplement registers the Put Shares and warrant shares, allowing the facility to be drawn under its existing terms; it does not say that any shares were sold or that cash was received today. 〔1〕
The warrant sweetener increases the eventual dilution ceiling. Alongside the possible 5 million shares, Hudson received a five-year warrant for 275,000 shares at a nominal $0.01 exercise price.
Bottom line: This is a financing-enablement filing, not a new strategic or operating development. It modestly improves Eva Live’s funding flexibility, while leaving the timing and scale of any actual issuance—and the resulting dilution—unknown.
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!